Advocacy

Advocacy Research Treatments

What is Meant by “Informed Consent”?

*August 2022* By EGFR Resisters Co-founder Ivy Elkins for Lungcancer.net Unless you have participated in a clinical trial, you might not be familiar with the term “informed consent,” commonly used to refer to the document that patients are given when they are considering signing up for a trial. This document…

laurabbook@gmail.comSeptember 24, 2022

Advocacy

FDA Workshop: Opportunities to Improve Dose Optimization: Designing Trials and Applying Pharmacometrics

*May 2022* EGFR Resisters co-founder Jill Feldman participated as a panelist in this FDA Oncology Workship: 3a "Opportunities to Improve Dose Optimization: Designing Trials and Applying Pharmacometrics; and 3b "Opportunities to Improve Dose Optimization: Assessing Safety and Tolerability." Current strategies for determining the recommended dose(s) of anticancer agents for evaluation…

laurabbook@gmail.comJuly 3, 2022

Jill Feldman - EGFR resisters group founder

Advocacy

I Don’t Want to Survive, I Want to Live

*April 2022* Video: Jill Feldman, co-founder of the EGFR Resisters and Stage 4 lung cancer survivor since 2009, speaks about survivorship at ELCC. Even care Watch video here.

laurabbook@gmail.comJune 29, 2022

Advocacy

Keeping Your Work Focused on Patients, Ivy Elkins, presenter

*February 2022* EGFR Resisters Co-Founder Ivy Elkins gave a presentation on “Keeping Your Work Focused on Patients" at the IASLC 2022 Targeted Therapies of Lung Cancer Meeting. This presentation was part of a special Early Career Workshop aimed at young investigators and focused on critical topics of interest to them…

laurabbook@gmail.comMarch 23, 2022

Advocacy Research Treatments

Video: Who’s in? Who’s out? How Patients Are Selected for Clinical Trials

*January 2022* In this video, EGFR Resisters co-founder Jill Feldman discusses this topic with Dr. Jorge J Nieva of USC Norris Comprehensive Cancer Center.

laurabbook@gmail.comMarch 16, 2022

Advocacy Research Treatments

Video: Clinical Trial Life Cycle

*January 2022* In this video, EGFR Resisters co-founders Jill Feldman and Ivy Elkins gave a presentation about the clinical trial life cycle. It starts at about 1:50.

laurabbook@gmail.comMarch 16, 2022

Advocacy Research Treatments

Cracking the Code on Non-Small Cell Lung Cancer in Younger Adults

*December 2021* There is a growing cohort of younger adults who are being diagnosed with lung cancer under 40 years of age. Alarmingly, the research points to an increase not only in diagnosis at a young age—but particularly in women. Although the average age for a lung cancer diagnosis is…

laurabbook@gmail.comDecember 7, 2021

Advocacy Research Treatments

What Can you Expect from a Lung Cancer Clinical Trial

*November 2021* In this webinar, Dr. Mark A. Socinski, Executive Medical Director, Advent Health Cancer Institute, Orlando, FL, will explain the process of participating in a lung cancer clinical trial from beginning to end. Dr. Socinski will explain how typical lung cancer clinical trials are structured, how patients are monitored…

laurabbook@gmail.comDecember 7, 2021

Advocacy Research Treatments

Advancing Person-Centered Care Through Innovation

*November 2021* Listen to EGFR Resisters co-founder Jill Feldman's presentation at ASTRO — innovating for clinically meaningful benefits that matter to patients. The final session of the symposium was a lively debate on randomized clinical trials versus real world data. Four speakers offered points/counterpoints for randomized clinical trials versus…

laurabbook@gmail.comNovember 12, 2021

Advocacy Funding

EGFR Resisters and LCRF Research Partnership

*November 2021* RESEARCH=SURVIVAL! As you may know, we have increased our goal to $225K to keep fundraising for additional research projects that we will fund through our collaboration with LCRF in 2022. These research projects will be dedicated to EGFR+ lung cancer and hopefully lead to discoveries that will provide…

laurabbook@gmail.comNovember 12, 2021

What is Meant by “Informed Consent”?

FDA Workshop: Opportunities to Improve Dose Optimization: Designing Trials and Applying Pharmacometrics

I Don’t Want to Survive, I Want to Live

Keeping Your Work Focused on Patients, Ivy Elkins, presenter

Video: Who’s in? Who’s out? How Patients Are Selected for Clinical Trials

Video: Clinical Trial Life Cycle

Cracking the Code on Non-Small Cell Lung Cancer in Younger Adults

What Can you Expect from a Lung Cancer Clinical Trial

Advancing Person-Centered Care Through Innovation

EGFR Resisters and LCRF Research Partnership

GIVE TODAY

Categories

STAY CONNECTED

You Might Like

BECOME A MEMBER

QUICK LINKS

WHO WE ARE

PROJECTS

ALLIANCES & RESOURCES